{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35497929", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "04", "Day": "22"}], "Language": ["eng"], "ELocationID": ["3707647", "10.1155/2022/3707647"], "Journal": {"ISSN": "1741-427X", "JournalIssue": {"Volume": "2022", "PubDate": {"Year": "2022"}}, "Title": "Evidence-based complementary and alternative medicine : eCAM", "ISOAbbreviation": "Evid Based Complement Alternat Med"}, "ArticleTitle": "Topical Formulation of Noscapine, a Benzylisoquinoline Alkaloid, Ameliorates Imiquimod-Induced Psoriasis-Like Skin Lesions.", "Pagination": {"StartPage": "3707647", "MedlinePgn": "3707647"}, "Abstract": {"AbstractText": ["Psoriasis is considered an autoimmune inflammatory disease. The disease is spread and diagnosed by the infiltration of inflammatory mediators and cells into the epidermis. Recent theoretical developments have focused on the effectiveness of noscapine (NOS) as a potential alkaloid for being used as a valuable treatment for different diseases. In the present study, psoriasis-like dermatitis was induced on the right ear pinna surface of male <i>Balb/c</i> mice by topical application of imiquimod (IMQ) for ten consecutive days, which was treated with noscapine (0.3, 1, 3, and 10% w/v) or clobetasol (0.05% w/v) as a positive control. The levels of ear length, thickness, severity of skin inflammation, psoriatic itch, psoriasis area severity index (PASI) score, and body weight were measured daily. On the 10<sup>th</sup> day of study, each ear was investigated for inflammation, fibrosis, proliferation, and apoptosis using histopathological (H&E and Masson's trichrome staining) and immunohistochemistry (Ki67 and p53 staining) assays. Furthermore, the levels of inflammatory biomarkers were characterized by an enzyme-linked immunosorbent assay (ELISA). The results confirmed IMQ-induced psoriasis for five consecutive days. In contrast, noscapine significantly reduced the ear length, thickness, severity of skin inflammation, psoriatic itch and body weight, tumor necrosis factor-<i>\u03b1</i> (TNF-<i>\u03b1</i>), transforming growth factor-<i>\u03b2</i> (TGF-<i>\u03b2</i>), interferon-gamma (IFN-<i>\u03b3</i>), interleukin 6 (IL-6), IL-17, and IL-23p19 in a concentration-dependent manner (<i>P</i>\u2009<\u20090.001-0.05 for all cases). Overall, topical noscapine significantly ameliorated both the macroscopical and microscopical features of psoriasis. However, further clinical investigations are required to translate the effects to clinics."], "CopyrightInformation": "Copyright \u00a9 2022 Fahimeh Nourbakhsh et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Toxicology Research Centre, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Nourbakhsh", "ForeName": "Fahimeh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Toxicology Research Centre, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Mousavi", "ForeName": "Seyed Hadi", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Rahmanian-Devin", "ForeName": "Pouria", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cardiovascular Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Baradaran Rahimi", "ForeName": "Vafa", "Initials": "V"}, {"Identifier": ["0000-0002-2118-1096"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Rakhshandeh", "ForeName": "Hassan", "Initials": "H"}, {"Identifier": ["0000-0001-9268-6270"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences in Persian Medicine, School of Persian and Complementary Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Department of Persian Medicine, School of Persian and Complementary Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Askari", "ForeName": "Vahid Reza", "Initials": "VR"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Evid Based Complement Alternat Med", "NlmUniqueID": "101215021", "ISSNLinking": "1741-427X"}, "CoiStatement": "The authors declare that they have no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Askari V. R., Rahimi V. B., Zargarani R., Ghodsi R., Boskabady M., Boskabady M. H. Anti-oxidant and anti-inflammatory effects of auraptene on phytohemagglutinin (PHA)-induced inflammation in human lymphocytes. Pharmacological Reports . 2021;73(1):154\u2013162. doi: 10.1007/s43440-020-00083-5.", "ArticleIdList": ["10.1007/s43440-020-00083-5", "32166733"]}, {"Citation": "Askari V. R., Baradaran Rahimi V., Tabatabaee S. A., Shafiee-Nick R. Combination of imipramine, a sphingomyelinase inhibitor, and \u03b2-caryophyllene improve their therapeutic effects on experimental autoimmune encephalomyelitis (EAE) International Immunopharmacology . 2019;77 doi: 10.1016/j.intimp.2019.105923.105923", "ArticleIdList": ["10.1016/j.intimp.2019.105923", "31711937"]}, {"Citation": "Baradaran Rahimi V., Askari V. R., Mousavi S. H. Ellagic acid dose and time-dependently abrogates d-galactose-induced animal model of aging: investigating the role of PPAR-\u03b3. Life Sciences . 2019;232 doi: 10.1016/j.lfs.2019.116595.116595", "ArticleIdList": ["10.1016/j.lfs.2019.116595", "31238053"]}, {"Citation": "Baradaran Rahim V., Khammar M. T., Rakhshandeh H., Samzadeh-Kermani A., Hosseini A., Askari V. R. Crocin protects cardiomyocytes against LPS-Induced inflammation. Pharmacological Reports . 2019;71(6):1228\u20131234. doi: 10.1016/j.pharep.2019.07.007.", "ArticleIdList": ["10.1016/j.pharep.2019.07.007", "31670059"]}, {"Citation": "Boskabady M., Khazdair M. R., Bargi R., et al. Thymoquinone ameliorates lung inflammation and pathological changes observed in lipopolysaccharide-induced lung injury. Evidence-Based Complementary and Alternative Medicine . 2021;2021:10. doi: 10.1155/2021/6681729.6681729", "ArticleIdList": ["10.1155/2021/6681729", "PMC8024078", "33859710"]}, {"Citation": "Sticherling M. Psoriasis and autoimmunity. Autoimmunity Reviews . 2016;15(12):1167\u20131170. doi: 10.1016/j.autrev.2016.09.004.", "ArticleIdList": ["10.1016/j.autrev.2016.09.004", "27639838"]}, {"Citation": "Henseler T., Christophers E. Disease concomitance in psoriasis. Journal of the American Academy of Dermatology . 1995;32(6):982\u2013986. doi: 10.1016/0190-9622(95)91336-x.", "ArticleIdList": ["10.1016/0190-9622(95)91336-x", "7751469"]}, {"Citation": "Parisi R., Symmons D. P., Griffiths C. E., Ashcroft D. M. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. Journal of Investigative Dermatology . 2013;133(2):377\u2013385. doi: 10.1038/jid.2012.339.", "ArticleIdList": ["10.1038/jid.2012.339", "23014338"]}, {"Citation": "Gudjonsson J. E., Elder J. T. Psoriasis: epidemiology. Clinics in Dermatology . 2007;25(6):535\u2013546. doi: 10.1016/j.clindermatol.2007.08.007.", "ArticleIdList": ["10.1016/j.clindermatol.2007.08.007", "18021890"]}, {"Citation": "Loft N. D., Skov L., Rasmussen M. K., et al. Genetic polymorphisms associated with psoriasis and development of psoriatic arthritis in patients with psoriasis. PLoS One . 2018;13(2) doi: 10.1371/journal.pone.0192010.e0192010", "ArticleIdList": ["10.1371/journal.pone.0192010", "PMC5794107", "29389950"]}, {"Citation": "Neimann A. L., Porter S. B., Gelfand J. M. The epidemiology of psoriasis. Expert Review of Dermatology . 2006;1(1):63\u201375. doi: 10.1586/17469872.1.1.63.", "ArticleIdList": ["10.1586/17469872.1.1.63"]}, {"Citation": "Benhadou F., Mintoff D., Del Marmol V. Psoriasis: keratinocytes or immune cells\u2013which is the trigger? Dermatology . 2019;235(2):91\u2013100. doi: 10.1159/000495291.", "ArticleIdList": ["10.1159/000495291", "30566935"]}, {"Citation": "Flatz L., Conrad C. Role of T-cell-mediated inflammation in psoriasis: pathogenesis and targeted therapy. Psoriasis: Targets and Therapy . 2013;3:1\u201310. doi: 10.2147/ptt.s26339.", "ArticleIdList": ["10.2147/ptt.s26339"]}, {"Citation": "Deng Y., Chang C., Lu Q. The inflammatory response in psoriasis: a comprehensive review. Clinical Reviews in Allergy & Immunology . 2016;50(3):377\u2013389. doi: 10.1007/s12016-016-8535-x.", "ArticleIdList": ["10.1007/s12016-016-8535-x", "27025861"]}, {"Citation": "Ueyama A., Yamamoto M., Tsujii K., et al. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod. The Journal of Dermatology . 2014;41(2):135\u2013143. doi: 10.1111/1346-8138.12367.", "ArticleIdList": ["10.1111/1346-8138.12367", "24387343"]}, {"Citation": "El Tawdy A., Amin I. M., Abdel Hay R., Hassan A. S., Gad Z. S., Rashed L. A. Toll-like receptor (TLR) 7 expression in mycosis fungoides and psoriasis: a case\u2013control study. Clinical and Experimental Dermatology . 2017;42(2):172\u2013177. doi: 10.1111/ced.13008.", "ArticleIdList": ["10.1111/ced.13008", "28054376"]}, {"Citation": "Rashmi R., Rao K. S. J., Basavaraj K. H. A comprehensive review of biomarkers in psoriasis. Clinical and Experimental Dermatology . 2009;34(6):658\u2013663. doi: 10.1111/j.1365-2230.2009.03410.x.", "ArticleIdList": ["10.1111/j.1365-2230.2009.03410.x", "19558584"]}, {"Citation": "Gupta A. K., Browne M., Bluhm R. Imiquimod: a review. Journal of Cutaneous Medicine and Surgery . 2002;6(6):554\u2013560. doi: 10.1177/120347540200600607.", "ArticleIdList": ["10.1177/120347540200600607", "12362256"]}, {"Citation": "Sch\u00f6n M., Sch\u00f6n M. Imiquimod: mode of action. British Journal of Dermatology . 2007;157:8\u201313. doi: 10.1111/j.1365-2133.2007.08265.x.", "ArticleIdList": ["10.1111/j.1365-2133.2007.08265.x", "18067624"]}, {"Citation": "Shen S., O\u2019Brien T., Yap L. M., Prince H. M., McCormack C. J. The use of methotrexate in dermatology: a review. Australasian Journal of Dermatology . 2012;53(1):1\u201318. doi: 10.1111/j.1440-0960.2011.00839.x.", "ArticleIdList": ["10.1111/j.1440-0960.2011.00839.x", "22309324"]}, {"Citation": "Seetharaman J., Rajan S. Crystal and molecular structure of noscapine 1. Zeitschrift f\u00fcr Kristallographie-Crystalline Materials . 1995;210(2):111\u2013113."}, {"Citation": "Nourbakhsh F., Askari V. R. Biological and pharmacological activities of noscapine: focusing on its receptors and mechanisms. BioFactors . 2021;47(6):975\u2013991. doi: 10.1002/biof.1781.", "ArticleIdList": ["10.1002/biof.1781", "34534373"]}, {"Citation": "Rahmanian-Devin P., Baradaran Rahimi V., Jaafari M. R., Golmohammadzadeh S., Sanei-far Z., Askari V. R. Noscapine, an emerging medication for different diseases: a mechanistic review. Evidence-based Complementary and Alternative Medicine . 2021;2021:16. doi: 10.1155/2021/8402517.8402517", "ArticleIdList": ["10.1155/2021/8402517", "PMC8648453", "34880922"]}, {"Citation": "Chen X., Dang T.-T. T., Facchini P. J. Noscapine comes of age. Phytochemistry . 2015;111:7\u201313. doi: 10.1016/j.phytochem.2014.09.008.", "ArticleIdList": ["10.1016/j.phytochem.2014.09.008", "25583437"]}, {"Citation": "Singh H., Singh P., Kumari K., Chandra A., K Dass S., Chandra R. A review on noscapine, and its impact on heme metabolism. Current Drug Metabolism . 2013;14(3):351\u2013360. doi: 10.2174/1389200211314030010.", "ArticleIdList": ["10.2174/1389200211314030010", "22935070"]}, {"Citation": "Na Takuathung M., Wongnoppavich A., Panthong A., et al. Antipsoriatic effects of wannachawee recipe on imiquimod-induced psoriasis-like dermatitis in BALB/c mice. Evidence-Based Complementary and Alternative Medicine . 2018;2018:13. doi: 10.1155/2018/7931031.7931031", "ArticleIdList": ["10.1155/2018/7931031", "PMC5829332", "29619073"]}, {"Citation": "Sakai K., Sanders K. M., Youssef M. R., et al. Mouse model of imiquimod-induced psoriatic itch. Pain . 2016;157(11):2536\u20132543. doi: 10.1097/j.pain.0000000000000674.", "ArticleIdList": ["10.1097/j.pain.0000000000000674", "PMC5069152", "27437787"]}, {"Citation": "Jaafari A., Baradaran Rahimi V., Vahdati-Mashhadian N., et al. Evaluation of the therapeutic effects of the hydroethanolic extract of Portulaca oleracea on surgical-induced peritoneal adhesion. Mediators of Inflammation . 2021;2021:18. doi: 10.1155/2021/8437753.8437753", "ArticleIdList": ["10.1155/2021/8437753", "PMC8352699", "34381307"]}, {"Citation": "Feldman A. T., Wolfe D. Histopathology . Berlin, Germany: Springer; 2014. Tissue processing and hematoxylin and eosin staining; pp. 31\u201343.", "ArticleIdList": ["25015141"]}, {"Citation": "Foot N. C. The masson trichrome staining methods in routine laboratory use. Stain Technology . 1933;8(3):101\u2013110. doi: 10.3109/10520293309116112.", "ArticleIdList": ["10.3109/10520293309116112"]}, {"Citation": "Park S. Y., Gupta D., Hurwich R., Kim C. H., Dziarski R. Peptidoglycan recognition protein Pglyrp2 protects mice from psoriasis-like skin inflammation by promoting regulatory T cells and limiting Th17 responses. The Journal of Immunology . 2011;187(11):5813\u20135823. doi: 10.4049/jimmunol.1101068.", "ArticleIdList": ["10.4049/jimmunol.1101068", "PMC3221838", "22048773"]}, {"Citation": "Hofman F. M., Taylor C. R. Immunohistochemistry. Current Protocols in Immunology . 2013;103(1):p. 21. doi: 10.1002/0471142735.im2104s103.", "ArticleIdList": ["10.1002/0471142735.im2104s103", "24510546"]}, {"Citation": "Grosset A.-A., Loayza-Vega K., Adam-Granger \u00c9., et al. Hematoxylin and eosin counterstaining protocol for immunohistochemistry interpretation and diagnosis. Applied Immunohistochemistry & Molecular Morphology . 2019;27(7):558\u2013563. doi: 10.1097/pai.0000000000000626.", "ArticleIdList": ["10.1097/pai.0000000000000626", "29271792"]}, {"Citation": "Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry . 1976;72(1-2):248\u2013254. doi: 10.1016/0003-2697(76)90527-3.", "ArticleIdList": ["10.1016/0003-2697(76)90527-3", "942051"]}, {"Citation": "Baradaran Rahimi V., Rajabian A., Rajabi H., et al. The effects of hydro-ethanolic extract of Capparis spinosa (C. spinosa) on lipopolysaccharide (LPS)-induced inflammation and cognitive impairment: evidence from in vivo and in vitro studies. Journal of Ethnopharmacology . 2020;256 doi: 10.1016/j.jep.2020.112706.112706", "ArticleIdList": ["10.1016/j.jep.2020.112706", "32109547"]}, {"Citation": "Curtis M. J., Bond R. A., Spina D., et al. Experimental design and analysis and their reporting: new guidance for publication in BJP. British Journal of Pharmacology . 2015;172(14):3461\u20133471. doi: 10.1111/bph.12856.", "ArticleIdList": ["10.1111/bph.12856", "PMC4507152", "26114403"]}, {"Citation": "George C. H., Stanford S. C., Alexander S., et al. Updating the guidelines for data transparency in the British Journal of Pharmacology - data sharing and the use of scatter plots instead of bar charts. British Journal of Pharmacology . 2017;174(17):2801\u20132804. doi: 10.1111/bph.13925.", "ArticleIdList": ["10.1111/bph.13925", "PMC5554317", "28801996"]}, {"Citation": "Alexander S. P. H., Roberts R. E., Broughton B. R. S., et al. Goals and practicalities of immunoblotting and immunohistochemistry: a guide for submission to the British Journal of Pharmacology. British Journal of Pharmacology . 2018;175(3):407\u2013411. doi: 10.1111/bph.14112.", "ArticleIdList": ["10.1111/bph.14112", "PMC5773976", "29350411"]}, {"Citation": "Bahali A. G., Onsun N., Su O., et al. The relationship between pruritus and clinical variables in patients with psoriasis. Anais Brasileiros de Dermatologia . 2017;92(4):470\u2013473. doi: 10.1590/abd1806-4841.20175402.", "ArticleIdList": ["10.1590/abd1806-4841.20175402", "PMC5595591", "28954093"]}, {"Citation": "Yosipovitch G., Goon A., Wee J., Chan Y., Goh C. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. British Journal of Dermatology . 2000;143(5):969\u2013973. doi: 10.1046/j.1365-2133.2000.03829.x.", "ArticleIdList": ["10.1046/j.1365-2133.2000.03829.x", "11069504"]}, {"Citation": "Kahremany S., Hofmann L., Harari M., Gruzman A., Cohen G. Pruritus in psoriasis and atopic dermatitis: current treatments and new perspectives. Pharmacological Reports . 2021;73(2):443\u2013453. doi: 10.1007/s43440-020-00206-y.", "ArticleIdList": ["10.1007/s43440-020-00206-y", "33460006"]}, {"Citation": "Valdimarsson H., Thorleifsdottir R. H., Sigurdardottir S. L., Gudjonsson J. E., Johnston A. Psoriasis\u2013as an autoimmune disease caused by molecular mimicry. Trends in Immunology . 2009;30(10):494\u2013501. doi: 10.1016/j.it.2009.07.008.", "ArticleIdList": ["10.1016/j.it.2009.07.008", "19781993"]}, {"Citation": "Vincent N., Ramya D. D., Vedha H. B. Progress in psoriasis therapy via novel drug delivery systems. Dermatology Reports . 2014;6(1) doi: 10.4081/dr.2014.5451.", "ArticleIdList": ["10.4081/dr.2014.5451", "PMC4224007", "25386329"]}, {"Citation": "Zwicky P., Unger S., Becher B. Targeting interleukin-17 in chronic inflammatory disease: a clinical perspective. Journal of Experimental Medicine . 2020;217(1) doi: 10.1084/jem.20191123.", "ArticleIdList": ["10.1084/jem.20191123", "PMC7037236", "31727781"]}, {"Citation": "Mahmoudian M., Rahimi-Moghaddam P. The anti-cancer activity of noscapine: a review. Recent Patents on Anti-Cancer Drug Discovery . 2009;4(1):92\u201397. doi: 10.2174/157489209787002524.", "ArticleIdList": ["10.2174/157489209787002524", "19149691"]}, {"Citation": "Desai P. R., Marepally S., Patel A. R., Voshavar C., Chaudhuri A., Singh M. Topical delivery of anti-TNF\u03b1 siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo. Journal of Controlled Release . 2013;170(1):51\u201363. doi: 10.1016/j.jconrel.2013.04.021.", "ArticleIdList": ["10.1016/j.jconrel.2013.04.021", "PMC3759511", "23643662"]}, {"Citation": "Sun J., Zhao Y., Hu J. Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice. PLoS One . 2013;8(6) doi: 10.1371/journal.pone.0067078.e67078", "ArticleIdList": ["10.1371/journal.pone.0067078", "PMC3692410", "23825622"]}, {"Citation": "Shaghaghi A., Alirezalu A., Nazarianpour E., Sonboli A., Nejad-Ebrahimi S. Opioid alkaloids profiling and anti-oxidant capacity of Papaver species from Iran. Industrial Crops and Products . 2019;142 doi: 10.1016/j.indcrop.2019.111870.111870", "ArticleIdList": ["10.1016/j.indcrop.2019.111870"]}, {"Citation": "Sung B., Ahn K. S., Aggarwal B. B. Noscapine, a benzylisoquinoline alkaloid, sensitizes leukemic cells to chemotherapeutic agents and cytokines by modulating the NF-\u03baB signaling pathway. Cancer Research . 2010;70(8):3259\u20133268. doi: 10.1158/0008-5472.can-09-4230.", "ArticleIdList": ["10.1158/0008-5472.can-09-4230", "PMC2855771", "20354190"]}, {"Citation": "Ebrahimi S. A. Noscapine, a possible drug candidate for attenuation of cytokine release associated with SARS-CoV-2. Drug Development Research . 2020;81(7):765\u2013767. doi: 10.1002/ddr.21676.", "ArticleIdList": ["10.1002/ddr.21676", "PMC7267448", "32337769"]}, {"Citation": "Tomar V., Kukreti S., Prakash S., Madan J., Chandra R. Noscapine and its analogs as chemotherapeutic agent: current updates. Current Topics in Medicinal Chemistry . 2016;17(2):174\u2013188. doi: 10.2174/1568026616666160530153518.", "ArticleIdList": ["10.2174/1568026616666160530153518", "27237331"]}, {"Citation": "Funding A. T., Johansen C., Kragballe K., et al. Mitogen-and stress-activated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-inflammatory cytokines. Journal of Investigative Dermatology . 2006;126(8):1784\u20131791. doi: 10.1038/sj.jid.5700252.", "ArticleIdList": ["10.1038/sj.jid.5700252", "16543895"]}, {"Citation": "Zughaier S., Karna P., Stephens D., Aneja R. Potent anti-inflammatory activity of novel microtubule-modulating brominated noscapine analogs. PLoS One . 2010;5(2) doi: 10.1371/journal.pone.0009165.e9165", "ArticleIdList": ["10.1371/journal.pone.0009165", "PMC2820095", "20161797"]}, {"Citation": "Kingo K., Koks S., Silm H., Vasar E. IL-10 promoter polymorphisms influence disease severity and course in psoriasis. Genes and Immunity . 2003;4(6):455\u2013457. doi: 10.1038/sj.gene.6364004.", "ArticleIdList": ["10.1038/sj.gene.6364004", "12944983"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "1", "Day": "6"}, {"Year": "2022", "Month": "3", "Day": "17"}, {"Year": "2022", "Month": "4", "Day": "5"}, {"Year": "2022", "Month": "5", "Day": "2", "Hour": "7", "Minute": "6"}, {"Year": "2022", "Month": "5", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "3", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "4", "Day": "22"}], "PublicationStatus": "epublish", "ArticleIdList": ["35497929", "PMC9054439", "10.1155/2022/3707647"]}}], "PubmedBookArticle": []}